EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
PDF) Ecological Validity of Virtual Reality Daily Living Activities Screening for Early Dementia: Longitudinal Study
![Ιωάννης Ταρνανάς: Ο Έλληνας ερευνητής που καινοτομεί στην πρώιμη διάγνωση του Αλτσχάιμερ [Συνέντευξη]](https://cdn.epixeiro.gr/craftuploads/_mainImage169/ternaras1.jpg?mtime=20181020142759 "Ιωάννης Ταρνανάς: Ο Έλληνας ερευνητής που καινοτομεί στην πρώιμη διάγνωση του Αλτσχάιμερ [Συνέντευξη]")
Ιωάννης Ταρνανάς: Ο Έλληνας ερευνητής που καινοτομεί στην πρώιμη διάγνωση του Αλτσχάιμερ [Συνέντευξη]
Ioannis Tarnanas's Page – iACToR
Ioannis Tarnanas (@ITarnanas) / Twitter
Ioannis Tarnanas (@ITarnanas) / Twitter
Ioannis Tarnanas | Nature Portfolio Health Community
2018 EIT Innovators Award Winner Ioannis Tarnanas | EIT
Ioannis Tarnanas (@ITarnanas) / Twitter
Dr. Ioannis Tarnanas, Ph.D. | LinkedIn
Greek Researcher Receives Top European Innovation Award (video)
Ioannis Tarnanas - Worldwebforum
Discover the venture case winners: A new way to fight Alzheimer`s disease and an insect-inspired micro-drone
Dr. Ioannis Tarnanas, Ph.D. - Founder - Altoida, Inc. | LinkedIn
Ιωάννης Ταρνανάς | Cretalive
Alzheimer europe virtual museum
TGL2019 - Dr. Ioannis Tarnanas - YouTube
Ioannis Tarnanas - Έλληνας ερευνητής κέρδισε ΕΙΤ Innovators Award | ellines.com
Evaluation of Three State-of-the-Art Classifiers for Recognition of Activities of Daily Living from Smart Home Ambient Data – topic of research paper in Medical engineering. Download scholarly article PDF and read for
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
